Table 2.
Clinical trials using nanoemulsions for cancer drug delivery.
| ClinicalTrial.gov ID | Active Compound | Nanoemulsion Constituents | Sponsor and Collaborators | Description | Status | Ref. |
|---|---|---|---|---|---|---|
| NCT02367547 | 5-Aminolevulinic acid | Soy phosphatidyl-choline; Propylene glycol |
Joint Authority for Päijät-Häme Social and Health Care; Tampere University; University of Jyvaskyla | Photodynamic therapy against superficial basal cell cancer. | Active, not recruiting | [122] |
| NCT03865992 | Curcumin | Data not available | City of Hope Medical Center; National Cancer Institute (NCI) | Oral curcumin nanoemulsion for joint pain reduction in breast cancer survivors caused by treatment with aromatase inhibitors. | Recruiting | [125] |
| NCT01975363 | Curcumin | Data not available | Ohio State University Comprehensive Cancer Center | Oral curcumin nanoemulsion to modulate pro-inflammatory biomarkers in plasma and breast adipose tissue. | Active, not recruiting | [127] |